Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Lafyatis

Showing results (1-10 of 196) with videos related to

Pageof 20
Sort By:
Endocrine, Metabolic & Immune Disorders Drug Targets|January 12, 2007
Targeting fibrosis in systemic sclerosisRobert Lafyatis
Current Rheumatology Reports|November 5, 2011
Application of biomarkers to clinical trials in systemic sclerosisRobert Lafyatis
Nature Reviews. Rheumatology|August 20, 2014
Transforming growth factor β--at the centre of systemic sclerosisRobert Lafyatis
The Open Rheumatology Journal|July 18, 2012
New insights into the mechanisms of innate immune receptor signalling in fibrosisRobert Lafyatis, Alessandra Farina
Nature Reviews. Rheumatology|July 20, 2022
Assessment of disease outcome measures in systemic sclerosisRobert Lafyatis, Eleanor Valenzi
Current Opinion in Rheumatology|July 28, 2009
Innate immunity and inflammation in systemic sclerosisRobert Lafyatis, Michael York
Arthritis Research & Therapy|November 12, 2010
The cytokine language of monocytes and macrophages in systemic sclerosisRomy B Christmann, Robert Lafyatis
Muscle & Nerve|April 5, 2011
Role for Toll-like receptor 3 in muscle regeneration after cardiotoxin injuryAllison L Mathes, Robert Lafyatis
Arthritis Research & Therapy|December 19, 2007
Toll-like receptors and innate immune responses in systemic lupus erythematosusRobert Lafyatis, Ann Marshak-Rothstein
Current Opinion in Rheumatology|October 21, 2006
Fibrillin in Marfan syndrome and tight skin mice provides new insights into transforming growth factor-beta regulation and systemic sclerosisRaphael Lemaire, Julie Bayle, Robert Lafyatis
Pageof 20

Showing results (1-10 of 196) with videos related to

Sort By:
Pageof 20
Endocrine, Metabolic & Immune Disorders Drug Targets|January 12, 2007
Targeting fibrosis in systemic sclerosisRobert Lafyatis
Current Rheumatology Reports|November 5, 2011
Application of biomarkers to clinical trials in systemic sclerosisRobert Lafyatis
Nature Reviews. Rheumatology|August 20, 2014
Transforming growth factor β--at the centre of systemic sclerosisRobert Lafyatis
The Open Rheumatology Journal|July 18, 2012
New insights into the mechanisms of innate immune receptor signalling in fibrosisRobert Lafyatis, Alessandra Farina
Nature Reviews. Rheumatology|July 20, 2022
Assessment of disease outcome measures in systemic sclerosisRobert Lafyatis, Eleanor Valenzi
Current Opinion in Rheumatology|July 28, 2009
Innate immunity and inflammation in systemic sclerosisRobert Lafyatis, Michael York
Arthritis Research & Therapy|November 12, 2010
The cytokine language of monocytes and macrophages in systemic sclerosisRomy B Christmann, Robert Lafyatis
Muscle & Nerve|April 5, 2011
Role for Toll-like receptor 3 in muscle regeneration after cardiotoxin injuryAllison L Mathes, Robert Lafyatis
Arthritis Research & Therapy|December 19, 2007
Toll-like receptors and innate immune responses in systemic lupus erythematosusRobert Lafyatis, Ann Marshak-Rothstein
Current Opinion in Rheumatology|October 21, 2006
Fibrillin in Marfan syndrome and tight skin mice provides new insights into transforming growth factor-beta regulation and systemic sclerosisRaphael Lemaire, Julie Bayle, Robert Lafyatis
Pageof 20